Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

The Dr. Oligo 192c High Throughput Oligo Synthesizer by Biolytic Lab Performance, Inc.

Biolytic introduces the Dr. Oligo 192c - their latest, most advanced synthesizer at a lower price


News provided by

Biolytic Lab Performance Inc.

Dec 04, 2018, 16:00 ET

Share this article

Share toX

Share this article

Share toX

Dr. Oligo 192c
Dr. Oligo 192c

FREMONT, Calif., Dec. 4, 2018 /PRNewswire-PRWeb/ -- Biolytic Lab Performance Inc. is proud to announce their latest high throughput oligo synthesizer, the Dr. Oligo 192c, built on Biolytic's Molecule Synthesis Platform.

Now restructured with all the same principles and key design aspects that have allowed them to become the world's fastest in oligonucleotide synthesis, the 192c incorporates a multitude of enhancements to new and existing Biolytic features.

This new instrument was built for operation in research and production facilities.

Post this

As the demand for highly parallel synthesis of standard and modified oligos has expanded - many labs needing 20 to 30 instruments just to keep up – Biolytic continuously designs instruments to accommodate the growing market. The 192c is no exception. It synthesizes up to 192 high quality oligos in one run, and is fast, secure and compact. This new instrument was built for operation in research and production facilities.

After evaluating needs in the market, the company's Founder and President, Tom Demmitt, says there were two main objectives behind the creation of the Dr. Oligo 192c. First, "it was time to redesign our original instrument to incorporate all of the enhancements we added to the basic design over the years," and second, "cost reduction." The 192c is Biolytic's most affordable synthesizer. It came to life through innovative ideas of quality improvement and upgraded features, but most importantly, cost-efficiency. This has allowed them to provide all the key functions of their previous design - along with improved user experience, increased efficiency and outstanding reliability - all at a reduced price for their customers. "Reducing capital equipment costs cuts down expenses and allows labs to expand faster, which many of our customers are looking to do," says Demmitt.

Another highlight of the 192c is a revamped reagent delivery system. It was designed with modern control boards and software, along with a more efficient layout and smaller valves to eliminate unnecessary waste. Demmitt shared, "these adjustments have allowed us to make accurate and consistent dispensing volumes down to 2ul."

Dr. Oligo 192c Features:

1. 40%* reduction in total volume, taking up a fraction of the space in your lab

2. Flexibility with up to 10 reagents (4 standard amidites and 6 special amidites)

3. Secure Bottle Containment System

  •      Bottles isolated behind a transparent door to ensure safety of the instrument and its operators
  •      Sealed catch tray leads directly to waste

4. Built on Biolytic's Molecule Synthesis Platform

  •      Open protocols
  •      Consistent delivery of reagents
  •      Hardware monitoring system
  •      Secure and encrypted
  •      Open and driverless hardware support

5. Driverless Biolytic Control Boards

  •      Antistatic and shockproof design
  •      On-board timing
  •      Valve short & valve flood protection
  •      Real-time valve monitoring

6. Industry leading design for simple maintenance

7. Side-by-side slider plate windows for improved visibility of reaction plates

8. Biolytic Certified Instrument Training

*Excludes slider plate

About Biolytic
Biolytic® Lab Performance, Inc. designs, manufactures and sells the most advanced oligo synthesizers in the world. Founded in 1993 by four of the leading experts in the biotech instrument service industry, Biolytic continues to provide superior quality, innovative products and esteemed services that push the limits of research and technology.

Customers all over the world use nucleic acids produced by our Dr. Oligo synthesizers for their own unique purposes. From applications like oligonucleotide and gene synthesis, genetic test kits, PCR/RT-PCR, siRNA/RNAi, miRNA, CRISPR Cas9, and DNA/RNA sequencing - to broader areas like evolutionary history, forensics, immunotherapy, diagnostic and therapeutic research – to high-throughput screening, natural product biosynthesis, reverse transcription PCP, hybridization, and SNPS – the variety is tremendous. Recently some have even endeavored into using nucleic acids as computer information storage devices, storing animated videos in DNA. The Dr. Oligo line has evolved alongside these cutting-edge discoveries, and it will continue to play a significant role in modern science with the Dr. Oligo 192c.

For more information please visit https://biolytic.com.

SOURCE Biolytic Lab Performance Inc.

Related Links

http://www.biolytic.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.